Esperion Therapeutics Inc (ESPR)
Esperion Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Esperion Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Lifeward to Report Second Quarter Financial Results on August 14, 2025
New Form 8-K - Tharimmune, Inc. Filed: 2025-08-07 AccNo: 0001641172-25-022615 Size: 229 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits